Re: Farmas USA
Actc
Advanced Cell secures equity facility • 9:24 AM
Advanced Cell Technology (ACTC) enters into a $30M common stock purchase agreement with Lincoln Park Capital Fund LLC. Under the terms of the agreement, after the SEC declares its registration statement effective, ACTC will have the right to sell up to $30M worth of common shares to LPC over a 36-month period. The company issued common shares to LPC as payment for its commitment fee.
Read comments
ACTC price at time of publication: $0.07. Check ACTC price now »
Was this email forwarded to you? Learn more about Seeking Alpha Alerts here »
Focus Articles on ACTC
ACTC: Have The Stars Finally Aligned For A Breakout Year? by Biotech Research Group
The Inflection Point For Stem Cells: An Interview With Advanced Cell Technology's Management by BiotechScout
Advanced Cell Technology's Conference Call Recap And Analysis by JMY Investments
More News on ACTC
New leader at Antares Jun 24, 11:17 AM ET (Seeking Alpha)
Press Releases on ACTC
Advanced Cell Technology Secures $30 Million Equity Facility from Lincoln Park Capital (Business Wire)
Advanced Cell Technology, Inc. Announces Paul K. Wotton Ph.D. Recognized as Ernst & Young (EY) 2014 Entrepreneur of the Year™ for New Jersey Region (Business Wire)
Advanced Cell Technology Appoints Paul K. Wotton, Ph.D, President and Chief Executive Officer (Business Wire)
Related Articles on ACTC
StemCells, Inc: Expect Positive Trial Results To Drive The Stock Price Higher by JMY Investments
BioTime Joins Advanced Cell Technology In The AMD Race by JMY Investments
Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS by JMY Investments
StockTalk on ACTC: ACTC StockTalk | Twitter ACTC | Twitter $ACTC | ACTC Instablogs
Recent Market Alerts on ACTC: All news | Earnings | Dividends | M&A | On the move
Transcripts on ACTC
Advanced Cell Technology's CEO Discusses Q3 2013 Results - Earnings Call Transcript by SA Transcripts
Advanced Cell Technology's CEO Hosts 2013 Annual Shareholders Meeting (Transcript) by SA Transcripts
Advanced Cell Technology's CEO Discusses Q2 2013 Results - Earnings Call Transcript by SA Transcripts
Why are you receiving this? You subscribed to real-time News alerts at Seeking Alpha.
If this email was forwarded to you and you wish to receive this email directly, click here.
Manage your emails:
Get alerts on additional tickers and manage all your email alert choices here
I’m getting too many emails: manage your email alert choices
I’m no longer following ACTC: unsubscribe from all ACTC email alerts
This type of alert isn't helpful to me: unsubscribe from Breaking News alerts on ACTC
To ensure you receive these emails in the future, please add [email protected] to your address book, contacts or list of safe senders.
Prices in this email are BATS Last Sale quotes.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001